フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
NewCardio Announces Financial Results for Its 2010 Fourth Quarter and Full Year Company Recognizes Initial Revenue, Further Penetrates Market and...
Top 5 Global Pharmaceutical Company Selects NewCardio's QTinno for 2 Upcoming Phase I Drug Safety Trials Fully Automated ECG Analysis, Empowered...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to...
NewCardio to Conduct Corporate Update Conference Call on March 29, 2011 Conference Call to Follow Release of Fourth Quarter 2010 Financial...
NewCardio Study of my3KG Performance in Diagnosis of AMI Selected for Presentation at the Society for Academic Emergency Medicine Annual...
NewCardio Study Shows CardioBip Detects Recurrent Atrial Fibrillation Earlier and More Reliably than Periodic Holter Monitoring Study to be...
NewCardio Study of my3KG Accuracy in Diabetic Patients to be Presented at the American College of Cardiology National Meeting Study shows my3KG...
NewCardio Study of QTinno Accuracy Selected for Presentation at the National Scientific Meeting of the American Society of Clinical Pharmacology...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________________ FORM 10-Q /A Amendment...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10- K/A AMENDMENT No. 1 (Mark One) x Annual...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or...
NewCardio Presents Results for Cardiac Safety Research Consortium Blinded Drug Safety Study QTinno reduces measurement variability and improves...
NewCardio's Chief Technical Officer, Dr. Dorin Panescu, Named 2011 IEEE Fellow PR Newswire SANTA CLARA, Calif., Dec. 2, 2010 SANTA CLARA, Calif...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________________ FORM 10-Q (Mark One) x...
Support
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す